Advanced Oxygen Therapy, based in Oceanside, strengthens its management team – North Coast Current

The company also announced the creation of an advisory board

Oceanside-based Advanced Oxygen Therapy Inc. announced several additions to its management team in February.

The company, which develops noninvasive wound healing solutions, has hired a new chief medical officer, chief strategy officer, president of US operations and vice president of reimbursements, the company said in a press release. Advanced Oxygen Therapy has also launched an industry scientific and clinical advisory board.

“I’m proud to have such industry powerhouses join our team,” the company’s president and CEO, Dr. Mike Griffiths, said in the release. “It’s a testament to and validation of the path we’re on to dramatically improve patient outcomes, reduce costs, and help address health inequities associated with non-healing wounds.”

Dr. Matthew G. Garoufalis – co-chair of the Alliance of Wound Care Stakeholders and past president of the American Podiatric Medical Association and the International Federation of Podiatrists – joins Advanced Oxygen Therapy as Chief Medical Officer.

The company’s new Chief Strategy Officer, Douglas WF LeFort, joins Advanced Oxygen Therapy after serving as CEO of Medtrade Products Ltd. and previously worked to launch ConvaTec Group’s $5.3 billion IPO.

President of Advanced Oxygen Therapy, USA, Chad Yount brings more than 25 years of senior management, sales and marketing experience in the specialty of wound care to his new role, the company said. Stacy Reel, new vice president of reimbursement and market access, also brings more than 20 years of experience to the company. Yount and Reel were also formerly affiliated with leading companies in the wound care industry such as ConvaTec.

In addition to the management team, Advanced Oxygen Therapy has also launched a scientific and clinical advisory board comprised of renowned experts in various disciplines related to wound care, such as diabetic foot ulcers, venous leg ulcers and salvage of limbs related to podiatry, orthopedics, vascular care. and plastic surgeries.

“It is exciting to help guide, together with my esteemed colleagues, the direction of clinical research and product development for such a dynamic company,” said Advisory Board Chairman Dr. Andrew Boulton, in the press release. “AOTI is clearly committed to establishing the highest quality clinical evidence for its products.”

Boulton is President of the International Diabetes Federation and Professor of Medicine at the University of Manchester.

More information is available online:

OsideNews is an Oceanside news site affiliated with North Coast Current.

encinitas current, cardiff curren

Comments are closed.